Bibliographic Details
| Title: |
Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer. |
| Authors: |
Seidman AD; Memorial Sloan-Kettering Cancer Center, Department of Medicine, Division of Solid Tumor Oncology, New York, NY 10065, USA. seidmana@mskcc.org, Conlin AK, Bach A, Moynahan ME, Lake D, Forero A, Wright GS, Hackney MH, Clawson A, Norton L, Hudis CA |
| Source: |
Clinical breast cancer [Clin Breast Cancer] 2013 Aug; Vol. 13 (4), pp. 239-246.e1. |
| Publication Type: |
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
